期刊文献+

利塞膦酸钠皮肤微透析方法的建立

Establishment of Skin Microdialysis Method for Risedronate Sodium
下载PDF
导出
摘要 目的建立利塞膦酸钠皮肤微透析方法。方法以利塞膦酸钠探针体外回收率为指标,采用增量法确定微透析试验中利塞膦酸钠的灌流速度及取样间隔;采用增量法和减量法考察灌流液流速及质量浓度对探针体外回收率和损失率的影响,以验证反透析法用于探针体内回收率测定的可行性。结果利塞膦酸钠探针体外回收率随流速的升高呈类线性下降。综合考虑试验因素,确定灌流速度为1.0μL/min,每次采样间隔为40 min,此条件下利塞膦酸钠的探针体外回收率为(45.85±0.63)%。在相同流速及温度下,不同质量浓度的利塞膦酸钠探针体外回收率变化不明显,且探针体外增量法回收率与减量法损失率相当(RSD=1.82%)。结论建立的利塞膦酸钠皮肤微透析方法可用于利塞膦酸钠经皮局部药效动力学研究。 Objective To establish a skin microdialysis method for risedronate sodium.Methods With the recovery rate of risedronate sodium as the index,the incremental method was used to determine the flow rate of perfusion fluid and sampling interval of risedronate sodium.The incremental method and decrement method were used to investigate the effect of flow rates and mass concentrations of perfusion fluid on the recovery rates and loss rates of the probe in vitro,so as to verify the feasibility of the reverse dialysis method applied to the determination of in vivo recovery rates of the probe.Results The in vitro recovery rates of risedronate sodium showed a similar linear decline trend with the increase of the flow rate.Combined with the comprehensive experimental factors,the flow rate of perfusion fluid was determined to be 1.0μL/min and the sampling interval was determined to be 40 min,and the in vitro recovery rate of the risedronate sodium probe was(45.85±0.63)%under this condition.When the flow rate and temperature of the perfusate remained constant,the in vitro recovery rates of the probe under different concentrations of risedronate sodium did not change significantly,and the in vitro recovery rates and loss rates of the probe were approximately equal(RSD=1.82%).Conclusion The established skin microdialysis method of risedronate sodium can be used for the study of the percutaneous absorption pharmacokinetics of risedronate sodium.
作者 梁俊晖 苏安宇 李亚欣 邓世森 杜锦颜 王利胜 LIANG Junhui;SU Anyu;LI Yaxin;DENG Shisen;DU Jinyan;WANG Lisheng(School of Pharmaceutical Sciences,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong,China 510006)
出处 《中国药业》 CAS 2023年第15期54-58,共5页 China Pharmaceuticals
基金 广东省广州市科技计划项目[202206010188] 广州中医药大学“双一流”与高水平大学学科协同创新团队培育项目[2021xk78]。
关键词 利塞膦酸钠 皮肤微透析 双膦酸盐 经皮给药 药效动力学 risedronate sodium skin microdialysis bisphosphonates transdermal drug delivery pharmacokinetics
  • 相关文献

参考文献10

二级参考文献125

  • 1杨帆,徐妙容,杨妙馥,林志恒,刘满堂,袁志辉.中药治疗骨质疏松症的用药规律(英文)[J].中国临床康复,2005,9(31):203-205. 被引量:6
  • 2刘丽芳,王宇新,李海燕,及莹.常用十字花科药用植物中芥子碱的分布研究[J].色谱,2006,24(1):49-51. 被引量:20
  • 3王锡娟,梁日欣,赵璐,高伟.中药复方骨疏康防治骨质疏松症研究进展[J].中国中西医结合杂志,2007,27(3):282-285. 被引量:12
  • 4姚红,童娟,王铮,张子谦,陈建雄.中药穴位敷贴疗法对哮喘大鼠肺组织中白细胞介素-4、γ干扰素表达的影响[J].针刺研究,2007,32(3):174-178. 被引量:21
  • 5Sir is ES, Chines AA, Ahman RD, et al. Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study[J]. J B one Miner Res, 1998, 13(6) : 1 032 - 1 038.
  • 6Usui T, Kawakami R, Watanabe T, et al. Sensitive determination of a novel bisphosphonate, YM 529, in plasma, urine and bone by high performance liquid chromatography with fluorescence detection[J]. J Chromatogr B, 1994, 652(1): 67-72.
  • 7Kwong E, Chiu AM, McClintock SA, et al. HPLC analysis of an amino bispho sphonate in pharmaceutical formulations using postcolumn derivation and fluo recence detection [J]. J Chromatogr Sci, 1990, 28 ( 11 ) : 563 - 566.
  • 8Van staa TP,Leufkens HGM,Cooper C,et al.The epidemiologyof corticosteroid-induced osteoporosis:a meta-analysis.OsteoporosisInt,2002,13(10):777-787.
  • 9Schacht E,Dukas L,Richy F,et al.Combined therapies inosteoporosis:bisphosphonates and vitamin D-hormone analogs.JMusculoskelet Neuronal Interact,2007,7(2):174-184.
  • 10Ettinger MP,Gallagher R,MacCosbe PE,et al.Medication persistewith weekly versus daily doses of orally administerbisphosphonates.Endocr Pract,2006,12(5):522-528.

共引文献480

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部